F. Bachelerie, A. Ben?baruch, A. Burkhardt, C. Combadiere, J. Farber et al., International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors, Pharmacological Reviews, vol.66, issue.1, pp.1-79, 2014.
DOI : 10.1124/pr.113.007724

E. Cormier and T. Dragic, The Crown and Stem of the V3 Loop Play Distinct Roles in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Interactions with the CCR5 Coreceptor, Journal of Virology, vol.76, issue.17, pp.8953-8957, 2002.
DOI : 10.1128/JVI.76.17.8953-8957.2002

C. Huang, M. Tang, M. Zhang, S. Majeed, E. Montabana et al., Structure of a V3-Containing HIV-1 gp120 Core, Science, vol.310, issue.5750, pp.1025-1028, 2005.
DOI : 10.1126/science.1118398

P. Kwong, R. Wyatt, J. Robinson, R. Sweet, J. Sodroski et al., Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody, Nature, vol.393, pp.648-659, 1998.

. Garcia?perez, 12:50 influencing gp120?CD4 interactions and fusogenicity, Retrovirology Virology, vol.410, pp.418-428, 2015.

P. Colin, Y. Benureau, I. Staropoli, Y. Wang, N. Gonzalez et al., HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines, Proceedings of the National Academy of Sciences, vol.110, issue.23, pp.9475-9480, 2013.
DOI : 10.1073/pnas.1222205110

URL : https://hal.archives-ouvertes.fr/pasteur-00825629

B. Connell, F. Baleux, Y. Coic, P. Clayette, D. Bonnaffe et al., A Synthetic Heparan Sulfate-Mimetic Peptide Conjugated to a Mini CD4 Displays Very High Anti- HIV-1 Activity Independently of Coreceptor Usage, Chemistry & Biology, vol.19, issue.1, pp.131-139, 2012.
DOI : 10.1016/j.chembiol.2011.12.009

URL : https://hal.archives-ouvertes.fr/hal-00664771

B. Doranz, S. Baik, and R. Doms, Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events, J Virol, vol.73, pp.10346-10358, 1999.

R. Berro, P. Klasse, D. Lascano, A. Flegler, K. Nagashima et al., Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors, Journal of Virology, vol.85, issue.16, pp.8227-8240, 2011.
DOI : 10.1128/JVI.00767-11

A. Flegler, G. Cianci, and T. Hope, CCR5 Conformations Are Dynamic and Modulated by Localization, Trafficking and G Protein Association, PLoS ONE, vol.31, issue.2, p.89056, 2014.
DOI : 10.1371/journal.pone.0089056.s004

S. Xiang, L. Wang, M. Abreu, C. Huang, P. Kwong et al., Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains, Virology, vol.315, issue.1, pp.124-134, 2003.
DOI : 10.1016/S0042-6822(03)00521-X

J. Julien, A. Cupo, D. Sok, R. Stanfield, D. Lyumkis et al., Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer, Science, vol.342, issue.6165, pp.1477-1483, 2013.
DOI : 10.1126/science.1245625

J. Kwon, S. Kim, S. Park, S. Choi, D. Lee et al., Isolates from Bacteremia and Nasal Colonization at 10 Intensive Care Units: Multicenter Prospective Study in Korea, Journal of Korean Medical Science, vol.26, issue.5, pp.604-611, 2011.
DOI : 10.3346/jkms.2011.26.5.604

M. Pancera, S. Majeed, Y. Ban, L. Chen, C. Huang et al., Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility, Proceedings of the National Academy of Sciences, vol.107, issue.3, pp.1166-1171, 2010.
DOI : 10.1073/pnas.0911004107

M. Cavrois, D. Noronha, C. Greene, and W. , A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes, Nature Biotechnology, vol.20, issue.11, pp.1151-1154, 2002.
DOI : 10.1038/nbt745

G. Melikyan, E. Platt, and D. Kabat, The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment, Retrovirology, vol.4, issue.1, p.55, 2007.
DOI : 10.1186/1742-4690-4-55

P. Tamamis and C. Floudas, Molecular Recognition of CCR5 by an HIV-1 gp120 V3 Loop, PLoS ONE, vol.43, issue.1387, p.95767, 2014.
DOI : 10.1371/journal.pone.0095767.s021

B. Lagane, J. Garcia?perez, and E. Kellenberger, Modeling the allosteric modulation of CCR5 function by Maraviroc, Drug Discovery Today: Technologies, vol.10, issue.2, pp.297-305, 2013.
DOI : 10.1016/j.ddtec.2012.07.011

URL : https://hal.archives-ouvertes.fr/pasteur-00743086

A. Marozsan, D. Moore, M. Lobritz, E. Fraundorf, A. Abraha et al., Differences in the Fitness of Two Diverse Wild-Type Human Immunodeficiency Virus Type 1 Isolates Are Related to the Efficiency of Cell Binding and Entry, Journal of Virology, vol.79, issue.11, pp.7121-7134, 2005.
DOI : 10.1128/JVI.79.11.7121-7134.2005

J. Reeves, S. Gallo, N. Ahmad, J. Miamidian, P. Harvey et al., Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics, Proceedings of the National Academy of Sciences, vol.99, issue.25, pp.16249-16254, 2002.
DOI : 10.1073/pnas.252469399

C. Agrawal?gamse, F. Lee, B. Haggarty, A. Jordan, Y. Yi et al., Adaptive Mutations in a Human Immunodeficiency Virus Type 1 Envelope Protein with a Truncated V3 Loop Restore Function by Improving Interactions with CD4, Journal of Virology, vol.83, issue.21, pp.11005-11015, 2009.
DOI : 10.1128/JVI.01238-09

E. Platt, J. Durnin, and D. Kabat, Kinetic Factors Control Efficiencies of Cell Entry, Efficacies of Entry Inhibitors, and Mechanisms of Adaptation of Human Immunodeficiency Virus, Journal of Virology, vol.79, issue.7, pp.4347-4356, 2005.
DOI : 10.1128/JVI.79.7.4347-4356.2005

C. Blanpain, J. Vanderwinden, J. Cihak, V. Wittamer, L. Poul et al., Multiple Active States and Oligomerization of CCR5 Revealed by Functional Properties of Monoclonal Antibodies, Molecular Biology of the Cell, vol.13, issue.2, pp.723-737, 2002.
DOI : 10.1091/mbc.01-03-0129

R. Berro, A. Yasmeen, R. Abrol, B. Trzaskowski, S. Abi?habib et al., Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants, Journal of Virology, vol.87, issue.12, pp.6569-6581, 2013.
DOI : 10.1128/JVI.00099-13

S. Mondal, G. Khelashvili, N. Johner, and H. Weinstein, How the Dynamic Properties and Functional Mechanisms of GPCRs Are Modulated by Their Coupling to the Membrane Environment, Adv Exp Med Biol, vol.796, pp.55-74, 2014.
DOI : 10.1007/978-94-007-7423-0_4

Y. Liu, N. Belkina, and S. Shaw, HIV Infection of T Cells: Actin-in and Actin-out, Science Signaling, vol.2, issue.66, p.23, 2009.
DOI : 10.1126/scisignal.266pe23

B. Harmon, N. Campbell, and L. Ratner, Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step, PLoS Pathogens, vol.75, issue.6, p.1000956, 2010.
DOI : 10.1371/journal.ppat.1000956.s012

R. Abrol, B. Trzaskowski, W. Goddard, A. Nesterov, I. Olave et al., Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor, Proceedings of the National Academy of Sciences, vol.111, issue.36, p.117, 2007.
DOI : 10.1073/pnas.1413216111

G. Lin, A. Bertolotti?ciarlet, B. Haggarty, J. Romano, K. Nolan et al., Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists, Journal of Virology, vol.81, issue.18, pp.9956-9966, 2007.
DOI : 10.1128/JVI.00385-07

K. Nolan, A. Jordan, and J. Hoxie, Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors, Journal of Virology, vol.82, issue.2, pp.664-673, 2008.
DOI : 10.1128/JVI.01793-07

S. Johnston, M. Lobritz, S. Nguyen, K. Lassen, S. Delair et al., A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains, Journal of Virology, vol.83, issue.21, pp.11016-11026, 2009.
DOI : 10.1128/JVI.01242-09

Y. Cheng and W. Prusoff, Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibi? tion (I50) of an enzymatic reaction, Biochem Pharmacol, vol.22, pp.3099-3108, 1973.

B. Lagane, S. Ballet, T. Planchenault, K. Balabanian, L. Poul et al., Mutation of the DRY Motif Reveals Different Structural Requirements for the CC Chemokine Receptor 5-Mediated Signaling and Receptor Endocytosis, Molecular Pharmacology, vol.67, issue.6, pp.1966-1976, 2005.
DOI : 10.1124/mol.104.009779

J. Jin, C. P. Staropoli, I. Lima?fernandes, E. Ferret, C. Demir et al., Targeting Spare CC Chemokine Receptor 5 (CCR5) as a Principle to Inhibit HIV-1 Entry, Journal of Biological Chemistry, vol.289, issue.27, pp.19042-19052, 2014.
DOI : 10.1074/jbc.M114.559831

URL : https://hal.archives-ouvertes.fr/pasteur-01027514

Y. Duan, C. Wu, S. Chowdhury, M. Lee, G. Xiong et al., A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations, Journal of Computational Chemistry, vol.44, issue.16, pp.1999-2012, 2003.
DOI : 10.1002/jcc.10349

B. Wu, E. Chien, C. Mol, G. Fenalti, W. Liu et al., Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists, Science, vol.330, issue.6007, pp.1066-1071, 2010.
DOI : 10.1126/science.1194396